CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 102 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.89 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,314,000 | -45.5% | 6,637,222 | +24.2% | 0.00% | -50.0% |
Q3 2018 | $2,410,000 | -3.1% | 5,343,599 | +22.1% | 0.00% | +100.0% |
Q2 2018 | $2,486,000 | +590.6% | 4,375,101 | +2733.4% | 0.00% | – |
Q1 2018 | $360,000 | -37.4% | 154,414 | -23.3% | 0.00% | -100.0% |
Q3 2017 | $575,000 | -33.2% | 201,214 | -42.3% | 0.00% | 0.0% |
Q2 2017 | $861,000 | -86.0% | 348,614 | -79.6% | 0.00% | -88.9% |
Q1 2017 | $6,166,000 | +45.2% | 1,707,927 | +42.4% | 0.01% | +28.6% |
Q4 2016 | $4,247,000 | -16.4% | 1,199,710 | -4.6% | 0.01% | -22.2% |
Q3 2016 | $5,083,000 | +49.1% | 1,258,214 | +62.0% | 0.01% | +50.0% |
Q2 2016 | $3,410,000 | +10.9% | 776,800 | -4.5% | 0.01% | 0.0% |
Q1 2016 | $3,074,000 | – | 813,331 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
Bellevue Group AG | 160,000 | $646,000 | 0.12% |
PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |